Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility Study of ATTN201 Centromedian Nucleus of the Thalamus Focused Ultrasound Stimulation for Enhanced Glymphatic Clearance in Amyloid Positive Patients With Mild Cognitive Impairment

NCT07866768 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07866768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility Study of ATTN201 Centromedian Nucleus of the Thalamus Focused Ultrasound Stimulation for Enhanced Glymphatic Clearance in Amyloid Positive Patients With Mild Cognitive Impairment
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2026
Completion date
January 31, 2028
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease (ad), mild cognitive impairment (mci), mild cognitive impairment (mci) due to alzheimer's disease